Medication info
Atrafen Tablet

Atrafen Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›37.5mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
Korea Prime Pharmaceutical Co., Ltd.
Appearance
Light yellow oblong film-coated tablet
Packaging
(For domestic use) 30 tablets/bottle, 300 tablets/bottle (For export) 50 tablets (10 tablets/PTP x 5)
Approval status
Active

MFDS item code 200804586 · Notified 2008.04.24 · Insurance code 663602810

Summary

Main use
Relief of moderate~severe acute·chronic pain
Who takes it
Adults · Children
Adult dose
Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years and older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this drug after dialysis to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.
Child dose
Pediatric patients aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and the total dose should not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
Korea Prime Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate~severe acute·chronic pain

  • Moderate to severe acute and chronic pain
View approved original text

This medication is used to relieve moderate to severe acute and chronic pain.

How to take

Adult dose

Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years and older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this drug after dialysis to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.

Child dose

Pediatric patients aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and the total dose should not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medication may pose a risk of liver damage for those who regularly consume more than three alcoholic drinks a day, so it is essential to consult a doctor or pharmacist. This medication can rarely cause severe skin reactions; therefore, if a skin rash or hypersensitivity occurs, you must stop taking it immediately. Due to the presence of tramadol, exceeding the recommended dose can increase the risk of seizures, and the risk is further heightened when taken with certain antidepressants or narcotics. In rare cases, fatal allergic reactions such as anaphylaxis may occur, so notify medical personnel immediately if unusual symptoms arise. Patients with acute or severe bronchial asthma face a risk of respiratory depression when using this medication, so it must be administered in a setting equipped with appropriate medical equipment. Taking this medication with alcohol or central nervous system inhibitors can lead to severe sedation and respiratory depression, so co-administration should be avoided or monitored carefully. Patients with increased intracranial pressure or head injuries should exercise caution with this medication, as respiratory depression may worsen symptoms. The tramadol in this medication can lead to psychological and physical dependence, so caution is necessary for prolonged use. Patients with reduced liver function must consult a doctor before taking this medication, and care should be taken to avoid taking it in combination with other acetaminophen formulations. Patients with a genetic predisposition to the rapid metabolism of the drug face a higher risk of respiratory depression, so dosage adjustment and monitoring are essential. This medication should not be administered to children under 12 years of age or to children after specific surgeries, and it should also be avoided in adolescents aged 12 to 18 if there are risk factors. This medication can cause sleep apnea or hypoxia, so its impact should be continuously evaluated. Elderly patients or those at risk of hyponatremia should be carefully monitored for symptoms of hyponatremia while on this medication. This medication is not administered to patients with hypersensitivity or certain conditions (severe respiratory depression, head injury, MAO inhibitors, etc.). When co-administered with other central nervous system depressants, the risk of sedation and respiratory depression increases, so it should be dosed at the minimal effective dose for the shortest duration, with careful observation of the patient's condition. Pregnant or breastfeeding individuals should consult a doctor before taking this medication, as it may pose risks to the fetus or newborn; it should not be taken while breastfeeding. Caution is necessary when driving or operating machinery due to potential drowsiness or dizziness. In case of overdose, serious respiratory depression, seizures, and liver damage may occur; therefore, the dosage must be strictly adhered to, and emergency treatment should be sought in case of overdose. This medication should be stored in a safe place out of the reach of children, and it is crucial to consult a doctor about potential interactions when taking it with other medications.

Side effects

  • Liver damage
  • acute generalized eruptive pustulosis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • seizures
  • anaphylactic reactions
  • respiratory depression
  • deep sedation
  • coma
  • hepatotoxicity
Show 179 more
  • hyponatremia
  • decreased appetite
  • insomnia
  • depression
  • dizziness
  • headache
  • drowsiness
  • nausea
  • vomiting
  • constipation
  • dry mouth
  • diarrhea
  • dyspepsia
  • abdominal pain
  • abdominal discomfort
  • flatulence
  • pruritus
  • sweating
  • rash
  • fatigue
  • flushing
  • urticaria
  • hypersensitivity
  • hypoglycemia
  • anxiety
  • nervousness
  • emotional instability
  • euphoria
  • decreased libido
  • sleep disorders
  • confusion
  • disorientation
  • excitement
  • abnormal dreams
  • drug abuse
  • hallucinations
  • withdrawal syndrome
  • migraine
  • somnolence
  • sensory loss
  • tremor
  • paresthesia
  • attention deficit
  • syncope
  • memory impairment
  • psychomotor agitation
  • sedation
  • amnesia
  • perceptual disturbances
  • convulsions
  • visual disturbances
  • visual impairment
  • miosis
  • dizziness
  • tinnitus
  • ear discomfort
  • palpitations
  • tachycardia
  • hypertension
  • hypotension
  • dyspnea
  • dry throat
  • increased liver enzymes
  • generalized pruritus
  • cold sweat
  • urinary disorders
  • erectile dysfunction
  • asthenia
  • chest pain
  • abnormal emotions
  • chills
  • chest discomfort
  • malaise
  • drug withdrawal syndrome
  • thirst
  • irritability
  • warmth sensation
  • weight loss
  • increased serum creatinine
  • anaphylactic reactions
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • emotional instability
  • delirium
  • suicidal ideation
  • hypertonia
  • movement disorders
  • serotonin syndrome
  • speech disorders
  • mydriasis
  • orthostatic hypotension
  • hepatitis
  • gait disorders
  • prolonged prothrombin time
  • fixed rash
  • asthenia
  • fever
  • edema
  • rigidity
  • syncope
  • congestive heart failure
  • vertigo
  • confusion
  • exacerbation of migraine
  • involuntary muscle contractions
  • dyspnea
  • asthma
  • exertional dyspnea
  • cough
  • bronchitis
  • urinary retention
  • frequent urination
  • abnormal kidney function tests
  • oliguria
  • increased sweating
  • urticaria
  • dysphagia
  • tongue swelling
  • increased salivation
  • progression of rectal cancer
  • progression of esophageal cancer
  • progression of stomach cancer
  • paralytic ileus
  • hiccups
  • cholecystitis
  • drowsiness
  • insomnia
  • decreased appetite
  • anxiety
  • depression
  • nervousness
  • emotional instability
  • hallucinations
  • depersonalization
  • anemia
  • decreased hemoglobin
  • decreased red blood cells
  • increased white blood cells
  • decreased platelets
  • palpitations
  • worsening hypertension
  • aortic stenosis
  • bleeding
  • increased cholesterol
  • tinnitus
  • chills
  • hip pain
  • thigh pain
  • allergic rhinitis
  • nasal bleeding
  • abnormal vision
  • progression of biliary cancer
  • foreign body sensation in the eye
  • progression of liver cancer
  • abnormal liver function
  • nausea
  • dizziness
  • paralytic ileus
  • cholecystitis
  • abnormal kidney function tests
  • increased salivation
  • bleeding
  • nausea
  • dizziness
  • dyspnea
  • confusion
  • migraine
  • speech disorders
  • loss of consciousness
  • recurrence of myocardial infarction
  • hypotension
  • vomiting
  • dyspepsia
  • confusion
  • multiple organ failure
  • anaphylaxis
  • intentional overdose
  • belching
  • chest discomfort

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture from entering, at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for a longer time.

Appearance and packaging

Appearance

Light yellow oblong film-coated tablet

Package unit

(For domestic use) 30 tablets/bottle, 300 tablets/bottle (For export) 50 tablets (10 tablets/PTP x 5)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.